Two Sigma Advisers LP Sells 63,100 Shares of Varex Imaging Co. (NASDAQ:VREX)

Two Sigma Advisers LP lessened its stake in Varex Imaging Co. (NASDAQ:VREX - Free Report) by 45.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 74,400 shares of the company's stock after selling 63,100 shares during the period. Two Sigma Advisers LP owned about 0.18% of Varex Imaging worth $1,085,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of VREX. Wealthfront Advisers LLC bought a new stake in Varex Imaging in the fourth quarter valued at approximately $18,900,000. Royce & Associates LP grew its holdings in Varex Imaging by 70.4% in the 4th quarter. Royce & Associates LP now owns 746,770 shares of the company's stock worth $10,895,000 after acquiring an additional 308,629 shares during the last quarter. Boston Partners purchased a new position in shares of Varex Imaging in the fourth quarter valued at about $8,718,000. AQR Capital Management LLC raised its stake in shares of Varex Imaging by 18.0% during the fourth quarter. AQR Capital Management LLC now owns 570,876 shares of the company's stock valued at $8,329,000 after acquiring an additional 87,098 shares during the last quarter. Finally, Russell Investments Group Ltd. boosted its holdings in shares of Varex Imaging by 510.7% during the fourth quarter. Russell Investments Group Ltd. now owns 471,612 shares of the company's stock worth $6,881,000 after purchasing an additional 394,381 shares during the period.

Varex Imaging Stock Down 0.1%

Varex Imaging stock traded down $0.01 during trading hours on Monday, hitting $7.66. 363,751 shares of the stock traded hands, compared to its average volume of 581,671. Varex Imaging Co. has a one year low of $6.76 and a one year high of $16.93. The firm's 50-day moving average price is $8.38 and its two-hundred day moving average price is $12.08. The company has a current ratio of 4.36, a quick ratio of 2.50 and a debt-to-equity ratio of 1.02. The company has a market cap of $315.59 million, a PE ratio of -6.55 and a beta of 0.62.

Varex Imaging (NASDAQ:VREX - Get Free Report) last released its quarterly earnings results on Thursday, May 8th. The company reported $0.26 earnings per share for the quarter, beating the consensus estimate of $0.14 by $0.12. The company had revenue of $212.90 million for the quarter, compared to analyst estimates of $206.76 million. Varex Imaging had a positive return on equity of 4.00% and a negative net margin of 5.79%. The firm's revenue was up 3.3% on a year-over-year basis. During the same period in the previous year, the company posted $0.16 earnings per share. On average, research analysts forecast that Varex Imaging Co. will post 0.53 EPS for the current year.

Analysts Set New Price Targets

A number of research analysts recently issued reports on VREX shares. Oppenheimer reduced their price target on Varex Imaging from $30.00 to $23.00 and set an "outperform" rating on the stock in a report on Friday, February 7th. Wall Street Zen cut Varex Imaging from a "strong-buy" rating to a "buy" rating in a research note on Thursday, May 22nd. Finally, B. Riley raised Varex Imaging to a "strong-buy" rating in a research note on Monday, May 12th.

Insider Activity at Varex Imaging

In other news, SVP Kimberley E. Honeysett sold 4,007 shares of the business's stock in a transaction that occurred on Thursday, March 20th. The stock was sold at an average price of $12.81, for a total value of $51,329.67. Following the sale, the senior vice president now directly owns 4,002 shares of the company's stock, valued at $51,265.62. The trade was a 50.03% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Sunny Sanyal sold 8,749 shares of the firm's stock in a transaction that occurred on Wednesday, April 2nd. The shares were sold at an average price of $11.24, for a total value of $98,338.76. Following the transaction, the chief executive officer now directly owns 190,193 shares of the company's stock, valued at approximately $2,137,769.32. This trade represents a 4.40% decrease in their position. The disclosure for this sale can be found here. 4.30% of the stock is currently owned by corporate insiders.

About Varex Imaging

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.